Frontiers in Immunology (May 2024)

Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibody

  • Adam S. Olia,
  • Madhu Prabhakaran,
  • Darcy R. Harris,
  • Crystal Sao-Fong Cheung,
  • Rebecca A. Gillespie,
  • Jason Gorman,
  • Jason Gorman,
  • Abigayle Hoover,
  • Nicholas C. Morano,
  • Nicholas C. Morano,
  • Amine Ourahmane,
  • Abhinaya Srikanth,
  • Shuishu Wang,
  • Weiwei Wu,
  • Tongqing Zhou,
  • Sarah F. Andrews,
  • Masaru Kanekiyo,
  • Lawrence Shapiro,
  • Lawrence Shapiro,
  • Lawrence Shapiro,
  • Adrian B. McDermott,
  • Peter D. Kwong,
  • Peter D. Kwong,
  • Peter D. Kwong

DOI
https://doi.org/10.3389/fimmu.2024.1399960
Journal volume & issue
Vol. 15

Abstract

Read online

The VH6-1 class of antibodies includes some of the broadest and most potent antibodies that neutralize influenza A virus. Here, we elicit and isolate anti-idiotype antibodies against germline versions of VH6-1 antibodies, use these to sort human leukocytes, and isolate a new VH6-1-class member, antibody L5A7, which potently neutralized diverse group 1 and group 2 influenza A strains. While its heavy chain derived from the canonical IGHV6-1 heavy chain gene used by the class, L5A7 utilized a light chain gene, IGKV1-9, which had not been previously observed in other VH6-1-class antibodies. The cryo-EM structure of L5A7 in complex with Indonesia 2005 hemagglutinin revealed a nearly identical binding mode to other VH6-1-class members. The structure of L5A7 bound to the isolating anti-idiotype antibody, 28H6E11, revealed a shared surface for binding anti-idiotype and hemagglutinin that included two critical L5A7 regions: an FG motif in the third heavy chain-complementary determining region (CDR H3) and the CDR L1 loop. Surprisingly, the chemistries of L5A7 interactions with hemagglutinin and with anti-idiotype were substantially different. Overall, we demonstrate anti-idiotype-based isolation of a broad and potent influenza A virus-neutralizing antibody, revealing that anti-idiotypic selection of antibodies can involve features other than chemical mimicry of the target antigen.

Keywords